Logo
⌂
Advisory
Pharma Signal
Career Support
About
Search
Log in
Free resources
Free resources

Your First 90 Days in Pharma Leadership

For new and newly promoted leaders

Medical Affairs Launch Readiness

Find the gaps before launch

After a Layoff: A 30-Day Plan

For pharma and biotech professionals in transition

Industry Opportunity Landscape

For clinicians and scientists moving into industry

All resources →

Guides, playbooks, and trainings

Subscribe
Request a discussion
Request a discussion

Leadership Advisory

For medical and scientific leaders

Medical Affairs & Field Strategy

Operating model, launch readiness, leadership scope

Field Medical Operating Model Assessment

For leaders who inherited a team

Workforce Transition

Restructuring and capability continuity

Strategic Market Advisory

For companies serving Medical Affairs

Sponsor Pharma Signal

Placements and rate card

Logo

LEADERSHIP ADVISORY

Leadership Advisory for Medical and Scientific Leaders

Practical, confidential support for medical and scientific leaders in pharma and biotech navigating people, priorities, and organizational dynamics.

Most leadership development happens in a program. The real test happens on an ordinary Tuesday: a tense one-on-one, a new VP, a reorg, a launch timeline that just moved. This is a place to think those situations through with someone who has led scientific teams through them.

Discuss the engagement

How it works ↓

Confidential

1:1 conversations stay private

Sponsor-aligned

Priorities agreed at kickoff

Practical

Real situations, not a curriculum

Fixed scope

Defined start, close, and investment

WHAT LEADERS BRING

The situations that don't fit into a training program

Internal mentors and HR partners rarely have the time or the scientific context. General executive coaching rarely knows how medical and scientific teams in pharma actually work. The sessions focus on what's in front of you right now.

Managing up and across

Aligning with a new VP, a matrixed program team, or a Commercial partner who sees it differently, and keeping your team's position clear.

Difficult conversations

Performance, expectations, and disagreement raised early and handled directly, before they become larger team problems.

Team dynamics

An inherited team, former peers who now report to you, or a group that isn't working well together yet.

Delegation

Moving from doing the work to leading it: what to hand off, to whom, and how to stay close without hovering.

Leading without direct authority

Being accountable for a study without owning every decision: getting into study decisions earlier, resolving friction with Clinical Operations, and making the medical implications clear before a decision is made.

Executive communication

Translating the science, and your team's impact, into what senior leadership needs to decide and act on.

Competing priorities

Deciding where your time and your team's time go when everything is labeled urgent, and saying no in a way that holds.

Leading through growth or launch

Building the team, standing up how it works, and keeping standards high while pace and visibility increase, whether that's a first pivotal readout or hiring MSLs ahead of launch.

HOW THE ENGAGEMENT WORKS

A defined start, focused working sessions, and a clear close

01 · KICKOFF

Agree on what matters

A 30-minute kickoff to agree on two or three priorities and what progress would look like. Your manager can join if that's useful.

02 · WORKING SESSIONS

Work the real situations

Regular 1:1 working sessions, typically every two to three weeks, focused on what's in front of you: the conversation you're preparing for, the decision you're weighing, the dynamic that isn't working. When useful, you'll get practical resources tied to what we discuss.

03 · CLOSING READOUT

Review progress

A closing readout to review the agreed goals, observable progress, and next priorities, with your manager if they joined the kickoff. What's discussed in the 1:1 sessions stays confidential. The engagement is completed within three to six months.

THE MANAGER'S ROLE

Involved where it helps

  • At kickoff (optional): agree on two or three priorities and what progress would look like.

  • At the close (optional): review the agreed goals, observable progress, and next priorities together.

  • Always: what's discussed in the 1:1 sessions stays confidential. A manager who joins sees goals and progress, not the content of the conversations.

WHAT SPONSORS TEND TO NOTICE

  • Clearer, faster calls on decisions that used to stall or get escalated

  • Medical input in cross-functional decisions before they're made, not after

  • A clear point of view in front of senior leadership

  • A team that knows what's expected and raises problems early

  • More delegation, and priorities that hold instead of everything landing on the leader

YOUR ADVISOR

Christine Ong, PharmD

Founder, Talmedica

20+ years across Clinical R&D, Regulatory, Medical Affairs, and Field Medical. Christine led clinical development programs at biotech companies, ran a regulatory and PK/PD consultancy, and later built, led, and redesigned Field Medical teams through launches and reorganizations at large and emerging companies.

She has managed up, across, and through the same situations leaders bring to these sessions, on both the clinical and the medical side.

INVESTMENT

$7,500

For the full engagement

  • 30-minute kickoff to set priorities (manager optional)

  • Regular 1:1 working sessions, typically every two to three weeks

  • Closing readout on goals, progress, and next priorities

  • Practical resources tied to the situations we discuss, when useful

  • Completed within three to six months

Discuss the engagement

Need to make the case internally? We can talk through how to frame the request on our first call. Invoice available for your organization.

Working with a whole leadership team? We also run facilitated team workshops on these same situations. Ask about it on the call.


Talmedica

Medical Affairs strategy, organizational design, and capabilities.

COMPANY

Advisory

Career Support

Resources

About

Contact

PHARMA SIGNAL

Subscribe

Recent issues

Sponsorship inquiries

ADDITIONAL SERVICES

Strategic Market Advisory

LinkedIn

Workforce Transition


© 2026 Talmedica LLC. All rights reserved.

Editorial independence

Confidentiality

Privacy

Terms

© 2026 Talmedica.
beehiivPowered by beehiiv